Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial - Top-Institutions - MDSpire

Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial

  • By

  • Hubert H. Fernandez

  • Stuart H. Isaacson

  • Robert A. Hauser

  • Pinky Agarwal

  • William Ondo

  • Ariane Park

  • Daniel Kremens

  • Matthew Leoni

  • Sridhar Duvvuri

  • Cari Combs

  • Erica Koenig

  • Ih Chang

  • Gina Pastino

  • Stacey Tringali

  • Nicole Golonski

  • Raymond Sanchez

  • Linda Harmer

  • Joey Boiser

  • Cindy Zadikoff

  • Zoltan Mari

  • May 1, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Neurology
    • Movement Disorders

  • #2

    University of South Florida
    University of South Florida

    Tampa, Florida

    Key Differentiators

    • Neurology
    • Movement Disorders

  • #3

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Neurology

  • #4

    Kyoto University
    Kyoto University

    Kyoto, Japan

    Key Differentiators

    • Neurology

  • #5

    Wakayama Medical University
    Wakayama Medical University

    Wakayama, Japan

    Key Differentiators

    • Neurology

Original Source(s)

Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial

  • by Hubert H. Fernandez, Stuart H. Isaacson, Robert A. Hauser, Pinky Agarwal, William Ondo, Ariane Park, Daniel Kremens, Matthew Leoni, Sridhar Duvvuri, Cari Combs, Erica Koenig, Ih Chang, Gina Pastino, Stacey Tringali, Nicole Golonski, Raymond Sanchez, Linda Harmer, Joey Boiser, Cindy Zadikoff, Zoltan Mari

  • May 1, 2026

Related Content

Incidence of anxiety disorders following Parkinson's disease: a population-based cohort study

Discrepancies in symptom concerns and burden from the perspectives of parkinson's disease patients, caregivers, and physicians

Advancing rehabilitation in Parkinson’s disease through virtual reality: a narrative review